Jazz Pharmaceuticals plc — Director's Dealing 2014

Aug 11, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2014-08-07

Reporting Person: Cox Russell J. (EVP & Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-08-07	Ordinary Shares	A	7500	—	Acquired	64532	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-08-07	Nonstatutory Stock Options (right to buy)	$135.44	A	15000	Acquired	2024-08-06	Ordinary Shares (15000)	Direct

Footnotes

F1: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in four successive equal annual installments on the anniversary of August 7, 2014.

F2: This option is granted pursuant to the Issuer's 2011 Equity Incentive Plan. This option vest with respect to 1/4 of the ordinary shares subject to this option on the first anniversary of August 7, 2014 and the remainder in 36 equal monthly installments thereafter.